Evidence map›Paper›PMID 40978629›Full record

ArticleBioinformation2025

Susceptibility and severity of Covid-19 in different blood groups.

Ritesh Upadhyay, Ravikant Mahale, Pawan Nandurkar, Sonali Tripathi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ritesh UpadhyayDepartment of Community Medicine, Chhindwara Institute of Medical Sciences, Mandhata, Shivam Sundaram Colony, Chhindwara, Madhya Pradesh 480001, Madhya Pradesh, India.
Ravikant MahaleDepartment of Pathology, Chhindwara Institute of Medical Sciences, Mandhata, Shivam Sundaram Colony, Chhindwara, Madhya Pradesh 480001, Madhya Pradesh, India.
Pawan NandurkarDepartment of Pediatrics, Chhindwara Institute of Medical Sciences, Mandhata, Shivam Sundaram Colony, Chhindwara, Madhya Pradesh 480001, India.
Sonali TripathiDepartment of Anesthesiology, Chhindwara Institute of Medical Sciences, Mandhata, Shivam Sundaram Colony, Chhindwara, Madhya Pradesh 480001, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relation of ABO and Rh blood groups with susceptibility and severity of COVID-19 among 120 patients is it of interest. Blood group A showed the highest infection rate of 37.5%, while the lowest was that of blood group O, at 20%. Susceptibility was a little higher in Rh-positive patients and the highest prevalence of severe disease was found among patients with blood group AB, at 30%. Results show that groups A and AB are associated with increased susceptibility and severity, which may help identify at-risk populations to target public health interventions. Further studies can help refine such associations and inform preventive strategies.

Indexed as

ABO blood groupCOVID-19observational studyRh factorseveritysusceptibility

Identifiers

PMID40978629
PMCPMC12449514

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.